SEO Title: Are Peptides Safe in Addiction Recovery? Uses, Risks & Safety

Written by John Ingham
on October 30, 2026
Posted in Uncategorized

Are Peptides Safe in Addiction Recovery? Understanding the Benefits, Risks, and Dangers of Self-Treatment

Peptide therapy has become a major topic in health and wellness, with people exploring these compounds for everything from injury recovery and inflammation to sleep, weight management, and cognitive function. For individuals recovering from drug or alcohol addiction, the interest can go even further. Some are looking for ways to improve their health after years of substance use, while others are considering peptides as an alternative to the drugs they are currently taking.

There is an important distinction between these situations. Peptides are not inherently dangerous, and several peptide-based medications have established safety and effectiveness when prescribed appropriately and used under medical supervision. However, many of the experimental peptides advertised online have not undergone the same clinical testing, and their long-term effects in humans remain uncertain.

The concern is not simply whether a substance is classified as a peptide. It is whether that particular compound has been adequately studied, whether the product comes from a legitimate source, and whether someone is using it for an appropriate medical reason rather than attempting to manage addiction or withdrawal without treatment.

At Sanctuary Treatment Center in Los Angeles, we recognize that people in recovery have legitimate reasons to pursue better physical and mental health. Understanding the difference between evidence-based peptide medications, investigational compounds, and unregulated online products is an important part of making informed decisions.

Key Points

Peptides are not inherently unsafe: Several FDA-approved medications are peptide-based, and appropriately prescribed treatments can be safe and beneficial for eligible patients.
Experimental peptides are different: BPC-157, TB-500, CJC-1295, Selank, and many other popular research peptides lack adequate human evidence to establish their safety and effectiveness for addiction recovery.
Peptides are not substitutes for addiction treatment: Attempting to replace alcohol, opioids, benzodiazepines, or other substances with experimental peptides can leave withdrawal symptoms, cravings, and other medical risks untreated.
Online sourcing creates additional risks: Unlicensed peptide sellers may provide products with inaccurate concentrations, contamination, questionable sterility, or ingredients that have not been independently verified.
Peptides in established recovery require individual consideration: Taking an appropriately prescribed medication does not automatically constitute relapse, but the medication’s purpose, medical necessity, and potential risks should be discussed with a qualified clinician.
How Sanctuary Helps: Sanctuary Treatment Center provides medical detox, residential addiction treatment, medication-assisted treatment, and continuing care for individuals navigating substance use and recovery.

What Are Peptides, and Why Are People Using Them?

Peptides are short chains of amino acids, the same building blocks that form proteins. Many occur naturally in the human body and help regulate biological processes involving hormones, metabolism, inflammation, tissue repair, and cellular communication.

Researchers have developed synthetic versions of certain peptides to investigate their potential medical applications. Some have become established prescription medications, while others remain experimental substances primarily studied in laboratories, animals, or small human trials.

The growing interest in peptide therapy is partly driven by the possibility of targeting specific biological processes. Rather than treating every symptom with the same medication, researchers are exploring compounds that interact with particular receptors or signaling pathways.

However, the fact that a peptide resembles a naturally occurring substance does not automatically make it safe. Its chemical structure, dose, method of administration, effects on other medications, and quality of manufacturing all influence its safety.

FDA-Approved Peptides vs. Research Peptides

One of the biggest sources of confusion is that legitimate prescription medications and experimental substances are frequently marketed under the same broad term: peptide therapy.

For example, semaglutide, the active ingredient in Ozempic and Wegovy, is a peptide-based medication with FDA-approved uses. Tirzepatide, found in Mounjaro and Zepbound, is another peptide-based medication used for specific metabolic indications. These medications have undergone clinical trials, although they still have side effects, contraindications, and prescribing requirements.

By comparison, compounds such as BPC-157, TB-500, and MOTS-c have not received FDA approval for treating addiction, withdrawal, or the various wellness conditions commonly advertised online.

There is also a difference between an FDA-approved drug and a compounded medication. Compounding by an appropriately licensed pharmacy can serve legitimate medical needs, but the FDA explains that compounded medications are not individually FDA-approved. A prescription alone does not establish that an experimental peptide is safe or effective.

Common Peptides People Are Exploring During Addiction Recovery

People interested in peptides after addiction treatment are not necessarily looking for a recreational effect. Many are seeking better sleep, reduced pain, improved energy, mental clarity, or help managing health problems that existed before or developed during active addiction.

Others may be attracted by claims that certain peptides can restore neurotransmitter function, reduce cravings, or accelerate recovery from substance-related damage. These claims deserve careful examination because the available evidence differs substantially between compounds.

BPC-157: Tissue Repair and Gastrointestinal Health

BPC-157 is a synthetic peptide frequently promoted for tissue healing, muscle and tendon recovery, gastrointestinal inflammation, and injury-related pain. Much of the enthusiasm comes from laboratory and animal research investigating its possible effects on tissue repair.

Someone recovering from alcohol or drug use may become interested in BPC-157 because of chronic pain, digestive problems, or concerns about physical damage associated with substance use.

However, BPC-157 is not FDA-approved for human treatment, and clinical evidence remains extremely limited. A 2026 systematic review of human BPC-157 research identified only three small studies involving 30 participants altogether, with very low certainty of evidence.

There is currently no established clinical evidence that BPC-157 can treat addiction, eliminate drug cravings, or safely manage withdrawal.

TB-500: Muscle Recovery and Inflammation

TB-500 is a synthetic peptide fragment associated with thymosin beta-4, a naturally occurring protein involved in cellular processes relevant to tissue repair. It is commonly promoted online for muscle recovery, injury rehabilitation, and inflammation.

Some people in recovery explore TB-500 after returning to exercise or attempting to address longstanding physical discomfort. Others encounter it through fitness communities that advertise combinations of TB-500 and BPC-157.

Although certain thymosin-related compounds have shown interesting effects in preclinical research, TB-500 itself lacks adequate human safety and effectiveness data. Claims that it can repair damage caused by addiction or improve recovery outcomes have not been established in clinical trials.

Selank: Anxiety and Stress Management

Selank is a synthetic peptide investigated for possible effects on anxiety, stress responses, and neurological signaling. It is sometimes marketed as a nootropic, meaning a substance intended to support cognitive function or mental performance.

This may appeal to people who previously used alcohol, benzodiazepines, or other substances to manage anxiety. Online discussions sometimes describe Selank as a potential alternative for calming symptoms without using traditional psychiatric medications.

However, Selank is not an FDA-approved treatment for anxiety, substance use disorders, or withdrawal in the United States. Its safety, appropriate dosing, interactions, and effectiveness for these purposes have not been adequately established through rigorous clinical research.

Semax: Focus, Motivation, and Cognitive Function

Semax is another synthetic peptide promoted for cognitive performance, attention, memory, and neurological recovery. Individuals who previously used stimulants such as cocaine, methamphetamine, or prescription amphetamines may encounter claims that Semax helps restore concentration and motivation.

These claims are especially appealing during early stimulant recovery, when fatigue, low motivation, difficulty concentrating, and disrupted sleep can be significant problems.

However, Semax has not been established as a safe or effective treatment for stimulant withdrawal or substance use disorders. Using an experimental compound to address these symptoms may also delay assessment of depression, sleep disorders, or other conditions that require appropriate care.

CJC-1295 and Ipamorelin: Growth Hormone Signaling

CJC-1295 and ipamorelin are frequently marketed together for muscle growth, body composition, sleep quality, and physical recovery. Both interact with biological pathways involved in growth hormone signaling, although they work through different mechanisms.

People recovering from prolonged substance use may become interested in these compounds when trying to regain strength, improve their physical appearance, or address feelings of fatigue.

However, growth hormone-related effects can influence glucose regulation, fluid balance, and other metabolic processes. These compounds are not FDA-approved for addiction recovery, and the FDA has identified safety concerns and important evidence gaps involving their use.

GHK-Cu: Skin, Hair, and Tissue Repair

GHK-Cu is a copper-binding tripeptide studied for its potential roles in skin health, wound healing, and tissue-related processes. It is commonly found in cosmetic discussions and marketed in various topical and injectable formulations.

For someone in recovery, the interest may come from wanting to improve skin appearance, address physical changes, or pursue general wellness.

It is important to distinguish topical cosmetic use from injectable administration. Safety information for a topical preparation cannot automatically be applied to an injectable product, and the FDA has identified limited human safety data and potential quality concerns involving compounded injectable GHK-Cu.

KPV: Inflammation and Gut Health

KPV is a three-amino-acid peptide fragment studied for possible anti-inflammatory properties. It is often discussed in connection with gastrointestinal conditions, skin inflammation, and immune responses.

Individuals recovering from heavy alcohol use or other substances may be interested in KPV because digestive symptoms and inflammation can be ongoing concerns.

Although early research is scientifically interesting, adequate human clinical evidence is lacking. The FDA has identified significant gaps in information about the safety of KPV-containing compounded products, including the absence of identified human exposure data.

MOTS-c: Metabolism and Cellular Energy

MOTS-c is a mitochondria-derived peptide being investigated for its relationship to metabolism, energy regulation, and cellular signaling. It has attracted attention in longevity and biohacking communities.

People in recovery may see it advertised as a way to address fatigue, poor exercise tolerance, or metabolic changes associated with prolonged substance use.

These potential uses remain experimental. MOTS-c is not FDA-approved, and human safety and effectiveness data are insufficient to support its use as an addiction recovery treatment.

DSIP: Sleep and Rest

Delta sleep-inducing peptide, commonly called DSIP, is marketed online for sleep quality, relaxation, and stress management. Its name makes it particularly attractive to people experiencing insomnia during or after substance withdrawal.

Sleep disturbances are common in recovery, but the presence of a peptide associated with sleep research does not establish that it effectively treats addiction-related insomnia.

There is insufficient high-quality clinical evidence supporting DSIP for this purpose, and people with persistent sleep problems should receive an evaluation rather than relying on unregulated experimental products.

GLP-1 Medications: Semaglutide and Tirzepatide

GLP-1 receptor agonists and related medications are among the most medically established peptide-based treatments. Semaglutide and tirzepatide have approved uses involving diabetes, weight management, and certain other conditions, depending on the specific product.

These medications have also attracted attention in addiction research because of possible effects on reward-related pathways and alcohol consumption.

Unlike many experimental peptides sold online, approved GLP-1 medications have substantial human clinical trial data. That does not mean they are appropriate for everyone, or that they are approved for treating addiction.

Their potential role in substance use disorder treatment is an emerging area of research that we will explore in greater detail later in this series.

Can Peptides Replace Drugs Someone Is Actively Using?

A person who wants to stop using drugs may begin searching for alternatives long before they are ready to enter formal treatment. They may encounter online claims suggesting that certain peptides can reduce anxiety, restore damaged neurotransmitter systems, improve sleep, or make withdrawal easier.

The desire to find a safer alternative is understandable. However, using experimental peptides to replace an addictive substance is not the same as receiving evidence-based addiction treatment.

Consider someone who has been taking Xanax daily and begins researching Selank because it is advertised for anxiety. Even if Selank eventually proves useful for certain conditions, it does not replace the medical precautions required when discontinuing benzodiazepines.

The same concern applies to someone attempting to replace opioids with peptides promoted for pain, inflammation, or emotional regulation. A product that may affect one symptom does not necessarily address physical dependence, opioid cravings, overdose risk, or the other components of opioid use disorder.

There is also the risk of continuing to use drugs while introducing experimental peptides. Interactions between these compounds, alcohol, illicit substances, and prescribed medications are often poorly studied.

Replacing one substance with another does not automatically resolve the underlying substance use disorder. When an individual needs medication to help manage withdrawal or maintain recovery, established treatments should be considered rather than assuming an experimental peptide can provide the same benefits.

Why Using Peptides to Detox at Home Can Be Dangerous

The term peptide detox sometimes appears in online discussions, where people describe attempting to use peptides, supplements, or combinations of compounds to stop taking drugs without professional supervision.

This is particularly concerning because withdrawal is not simply a matter of reducing inflammation, supporting sleep, or improving general wellness. Different substances produce different withdrawal syndromes, and some can become medically dangerous.

Alcohol Withdrawal

Someone who drinks heavily or regularly may experience tremors, sweating, agitation, nausea, rapid heart rate, and significant changes in blood pressure when alcohol use is reduced or stopped.

More severe alcohol withdrawal can involve seizures, hallucinations, and delirium tremens. These complications require medical treatment and cannot be reliably prevented by experimental peptides.

Individuals concerned about alcohol dependence should seek a professional assessment before abruptly stopping, particularly if they have experienced withdrawal symptoms in the past. Sanctuary provides medical detox in Los Angeles for individuals whose withdrawal risks require structured clinical support.

Benzodiazepine Withdrawal

Benzodiazepines such as Xanax, Klonopin, Ativan, and Valium can produce physical dependence with regular use, even when taken as prescribed. Abruptly discontinuing these medications may cause severe anxiety, insomnia, agitation, seizures, or other serious complications.

Some individuals have become interested in Selank, Semax, or other compounds as possible replacements for benzodiazepines. However, there is no adequate clinical evidence that these peptides can safely prevent benzodiazepine withdrawal.

The American Society of Addiction Medicine’s benzodiazepine tapering guidance emphasizes gradual, individualized dose reductions under medical supervision for patients at risk of withdrawal.

Opioid Withdrawal

Withdrawal from fentanyl, heroin, or prescription opioids can produce severe discomfort, gastrointestinal symptoms, dehydration, insomnia, restlessness, and intense cravings.

Although opioid withdrawal is not usually fatal by itself, complications and return to use can be dangerous. After a period of abstinence, reduced opioid tolerance can increase overdose risk if someone resumes using a previously tolerated amount.

There are established medical approaches to opioid withdrawal and ongoing opioid use disorder treatment. According to the FDA’s guidance on medications for opioid use disorder, buprenorphine, methadone, and naltrexone are approved treatment options, with different clinical considerations for each.

No experimental peptide should be assumed to provide equivalent treatment.

If someone is experiencing seizures, severe confusion, hallucinations, loss of consciousness, or other potentially life-threatening symptoms during withdrawal, emergency medical care is necessary. Peptide products should never delay appropriate treatment.

Are Peptides Safe After Someone Has Been in Recovery for a While?

There is an important difference between someone attempting to use peptides to avoid withdrawal and someone who has been in stable recovery for months or years and is considering treatment for an unrelated health condition.

An individual in long-term recovery may develop diabetes, obesity, a hormonal disorder, or another medical condition for which a peptide-based medication is appropriate. Their history of addiction does not automatically disqualify them from receiving necessary treatment.

Taking an FDA-approved peptide medication as prescribed for a legitimate medical condition does not inherently constitute relapse.

At the same time, people in recovery should be thoughtful about experimental treatments promoted for mood, energy, sleep, and performance. A substance may not produce a traditional intoxicating high, but that does not mean it has no medical risks or that its use cannot become part of an unhealthy pattern of self-treatment.

For some people, repeatedly experimenting with compounds to control every uncomfortable feeling can resemble previous patterns surrounding substance use. Others may find that self-injection, secrecy surrounding medication use, or escalating use despite negative consequences creates challenges for their recovery.

These concerns should be evaluated individually rather than treating every peptide or prescription medication as a threat to sobriety.

The most appropriate approach is to discuss the proposed treatment with a qualified medical professional who understands the person’s substance use history, current medications, physical health, and recovery goals.

The Biggest Concern With Online Peptides: Testing, Quality, and Regulation

One of the most significant risks associated with experimental peptides is the way they are sold.

Many websites advertise peptide products using pharmaceutical terminology, laboratory images, certificates of analysis, and claims about purity. Some products are labeled research use only or not for human consumption while being discussed online as substances people can inject or otherwise administer themselves.

These labels do not establish that the products are suitable for human use.

The FDA has warned about significant safety concerns involving certain compounded peptide substances, including potential immune reactions, impurities, and inadequate human safety information.

Potential problems with unregulated peptide products include:

Incorrect concentrations: The product may contain more or less active ingredient than the label indicates.
Contamination: Manufacturing, storage, or preparation problems may introduce microorganisms or other contaminants.
Unverified sterility: Injectable products require appropriate sterile manufacturing and handling standards that cannot be assumed from marketing claims.
Misidentified ingredients: A vial may contain an ingredient other than the one advertised or a combination not accurately disclosed.
Improper storage: Peptides may degrade under unsuitable conditions, affecting product quality.
Inadequate medical oversight: A website may sell experimental compounds without evaluating medical history, contraindications, or medication interactions.

Even a certificate of analysis does not automatically prove that the exact product received by a consumer was manufactured, stored, and tested appropriately for human administration.

Are All Online Pharmacies Unsafe?

No. Legitimate, state-licensed pharmacies may operate online and dispense approved prescription medications. Some appropriately licensed pharmacies also provide lawful compounded medications when there is a genuine patient-specific medical need.

The distinction is whether the business operates within applicable pharmacy regulations and provides the safeguards expected of a legitimate medical supplier.

The FDA’s BeSafeRx program recommends verifying pharmacy licensure, confirming that a valid prescription is required, and ensuring that a licensed pharmacist is available to answer questions.

A website selling unapproved injectable peptides directly to consumers without prescriptions or meaningful medical oversight should not be treated as equivalent to a legitimate pharmacy.

Could Peptides Eventually Become Part of Addiction Treatment?

It is possible that certain peptide-based medications could have a meaningful role in future addiction treatment. One of the most interesting developments involves GLP-1 medications and their potential effects on alcohol consumption.

A 2025 randomized clinical trial published in JAMA Psychiatry found that semaglutide reduced certain measures of alcohol consumption and craving compared with placebo. The study was relatively small, but its findings supported further research.

More recently, a 2026 randomized trial published in The Lancet evaluated semaglutide in 108 people with alcohol use disorder and obesity. Participants receiving semaglutide experienced a greater reduction in heavy drinking days than those receiving placebo, with both groups also offered cognitive behavioral therapy.

Another 2026 randomized clinical trial involving oral semaglutide reported reductions in some drinking outcomes, although its primary laboratory measure of alcohol craving did not significantly improve.

These findings are encouraging, but they do not mean GLP-1 medications are established treatments for alcohol addiction. As of October 2026, semaglutide and tirzepatide are not FDA-approved specifically for substance use disorders.

They also do not establish that unrelated experimental peptides, including BPC-157 or Selank, can produce similar effects.

Research may eventually expand the medical options available for addiction treatment. Until then, emerging therapies should be distinguished from treatments already supported by adequate clinical evidence.

How to Approach Peptide Therapy Responsibly in Recovery

Someone considering peptide therapy should begin by identifying the actual health concern they are trying to address.

For example, persistent fatigue could be related to disrupted sleep, depression, nutritional deficiencies, medication effects, or another medical condition. Chronic pain may require evaluation and a treatment plan rather than an experimental tissue-repair compound.

A qualified clinician can help determine whether an established treatment exists and whether a peptide-based medication has an appropriate role.

Important considerations include medical necessity, FDA approval status, human clinical evidence, source verification, possible interactions, appropriate monitoring, and any personal recovery-related concerns.

For individuals in early recovery, additional support may be helpful when navigating physical symptoms, emotional discomfort, and the desire for rapid improvements. Sanctuary’s dual diagnosis treatment addresses substance use alongside co-occurring mental health conditions that may contribute to these concerns.

The goal is not to discourage someone from pursuing better health. It is to ensure that the treatment they choose has a reasonable medical basis and does not create preventable risks.

How Sanctuary Treatment Center Supports Safer Recovery

At Sanctuary Treatment Center, we understand why someone struggling with addiction might be attracted to treatments promising improved energy, reduced anxiety, better sleep, or relief from withdrawal symptoms.

Many people have spent years feeling physically or emotionally unwell, and the idea of finding something that helps them feel better can be powerful. However, recovering from a substance use disorder requires more than finding a new compound that seems capable of managing certain symptoms.

Our medical detox program helps individuals manage withdrawal through individualized assessment, monitoring, and appropriate clinical care. For people who need additional structure, our residential treatment program provides a supportive environment for addressing substance use and related behavioral health concerns.

Sanctuary also offers medication-assisted treatment when clinically appropriate, allowing evidence-based medications to be incorporated into individualized addiction treatment.

As clients progress, our Partial Hospitalization Program and Intensive Outpatient Program can provide continuing structure while individuals rebuild routines and navigate everyday recovery challenges.

If you are currently using drugs or alcohol and considering peptides as a way to stop, we encourage you to speak with a qualified treatment professional before attempting to detox independently.

If you are already in recovery and considering peptide therapy for a legitimate health concern, discuss it with your prescribing clinician and recovery care team rather than relying on unverified online advice.

Contact Sanctuary Treatment Center to learn more about treatment options in Los Angeles.

Frequently Asked Questions About Peptides and Addiction Recovery

Are peptides considered drugs?

Some peptides are classified and regulated as medications, including several FDA-approved prescription treatments. Others are experimental compounds without FDA approval for human therapeutic use, and their availability online does not establish that they are legal, safe, or appropriate to administer.

Can peptides help with opioid withdrawal?

There is currently insufficient clinical evidence supporting experimental peptides such as BPC-157, Selank, or Semax for treating opioid withdrawal. Established medical approaches, including appropriate withdrawal management and medications for opioid use disorder, have substantially stronger evidence supporting their use.

Is BPC-157 safe for someone in addiction recovery?

There is not enough high-quality human research to establish BPC-157’s safety for this purpose. Individuals considering it for pain, gastrointestinal symptoms, or injury recovery should understand that it is not FDA-approved and that its proposed benefits remain largely investigational.

Does taking peptides count as breaking sobriety?

Not automatically. Using an appropriately prescribed medication for a legitimate medical condition is different from using an unregulated substance to pursue intoxication or avoid dealing with addiction. Personal recovery goals, medical necessity, and the circumstances of use all matter.

Can peptides repair damage caused by drugs or alcohol?

Some peptides are being studied for possible effects on tissue repair, inflammation, and cellular function, but claims that experimental peptides can reverse addiction-related damage are not supported by adequate human clinical evidence. Recovery from substance-related health problems should begin with appropriate medical evaluation and treatment of the underlying condition.

Can someone take peptides while receiving addiction treatment?

A person should disclose all prescribed medications, supplements, and experimental substances to their addiction treatment team. Whether a peptide-based medication is appropriate depends on its indication, safety profile, interactions, the individual’s health, and the treatment plan.

The Bottom Line: Peptides Are Not the Problem, but Unsupervised Experimentation Can Be

Peptide medicine is a legitimate and expanding area of medical research. Some peptide-based medications are already used successfully for established health conditions, and ongoing studies may identify additional clinical applications in the future.

The concern in addiction recovery is not that every peptide is dangerous or that people should avoid medical treatments simply because of their substance use history. It is that experimental compounds are increasingly being marketed with claims that go far beyond the available evidence.

Someone attempting to replace alcohol, opioids, benzodiazepines, or other drugs with unapproved peptides may be exposing themselves to withdrawal complications without receiving the treatment they need. Someone in stable recovery purchasing injectable research chemicals from an unlicensed online seller may face entirely different risks involving contamination, uncertain dosing, and unknown long-term effects.

Both situations deserve informed medical guidance rather than promises of a quick fix.

Peptides may have a place in legitimate medical care, but they should never be mistaken for a proven shortcut through addiction, withdrawal, or recovery.

Sources

American Society of Addiction Medicine. (2025). Benzodiazepine tapering: Joint clinical practice guideline. https://www.asam.org/quality-care/clinical-guidelines/benzodiazepine-tapering

Hendershot, C. S., et al. (2025). Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial. JAMA Psychiatry, 82(4), 395–405. https://doi.org/10.1001/jamapsychiatry.2024.4789

Klausen, M. K., et al. (2026). Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: A randomised, double-blind, placebo-controlled trial. The Lancet, 407(10540), 1687–1698. https://doi.org/10.1016/S0140-6736(26)00305-3

Poolton, J. T., Minett, J., & Kazmi, A. (2026). Human evidence for BPC-157 in orthopaedic and regenerative medicine: A systematic review of efficacy and safety. Acta Orthopaedica Belgica, 92(3). https://pubmed.ncbi.nlm.nih.gov/42885452/

Schacht, J. P., Sakai, J. T., Raymond, K., & Shelton, R. (2026). Oral semaglutide for alcohol use disorder: A randomized clinical trial. American Journal of Psychiatry, 183(9), 636–645. https://doi.org/10.1176/appi.ajp.20260003

Substance Abuse and Mental Health Services Administration. (2025). Substance use disorders treatment options. https://www.samhsa.gov/blog/substance-use-disorders-treatment-options

U.S. Food and Drug Administration. (n.d.). Certain bulk drug substances for use in compounding that may present significant safety risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

U.S. Food and Drug Administration. (2026). Compounding and the FDA: Questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

U.S. Food and Drug Administration. (2026). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

U.S. Food and Drug Administration. (2026). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/information-about-medications-opioid-use-disorder-moud

U.S. Food and Drug Administration. (n.d.). Locate a state-licensed online pharmacy. https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy